Short-acting Opioid Antagonist (e.g. Naloxone, nalmefene) Prescribing

Laws & Rules

• ORS 689.800 Opioid overdose; treatment; administration of short-acting opioid antagonist; liability; rules.
• ORS 689.802 Prescription of short-acting opioid antagonist.
  
• ORS 689.804 Administration of short-acting opioid antagonist by certain persons; rules.
  
• ORS 689.806 Notice of availability of short-acting opioid antagonist; rules.
  
• ORS 689.808 Short-acting opioid antagonist standing order; liability; rules
  
• ORS 689.811 Publicly accessible short-acting opioid antagonist; administration; liability; rules. 
  
• ORS 689.813 Exemption from drug labeling requirements.
  
• OAR 855-041-1035 Minimum Equipment Requirements
  
• OAR 855-115-0350 Services: Prescribing Practices - Short-acting Opioid Antagonists 
  

• Naloxone Access: A Practical Guideline for Pharmacists
  
• Instructions for Healthcare Providers: Prescribing Naloxone
• Good Samaritan Wallet Card
  
• Good Samaritan Wallet Card - Spanish 
• Oregon Health Authority: Opioid Overdose and Misuse Resources
  
• Oregon Health Authority: Short-acting Opioid Antagonist Standing Order 
  
• Oregon Health Authority: Written Naloxone Training
  
• Oregon Board of Pharmacy: Position Statement Sterile Syringe Access & Harm Reduction
  
• SAMHSA Opioid Overdose Prevention
  
• Stay Safe Oregon 
  
• Continuing Pharmacy Education Resources - *There is no formal certification for an Oregon pharmacist to prescribe naloxone, however licensees may be interested in related CPE, please see related CPE resources below: 
• Pharmacy Learning Assistance Network (ACPE) - Utilize this nationwide database to locate ACPE approved CPE on a specific topic (Opioids, Substance Use Disorder)
  
• Prescribe to Prevent